CompanyDrug

Hunan Warrant Pharmaceutical’s ZG-001 Approved for Clinical Trial by NMPA

CompanyDrug

VivaVision Biotech Inc. Receives FDA Approval for VVN461 Phase II Clinical Trial

CompanyDrug

AnHeart Therapeutics and Innovent Biologics File Taletrectinib for Marketing Approval in China

CompanyDeals

Genentech and NVIDIA Collaborate to Advance Drug Discovery with AI

CompanyDeals

MSD to Acquire Caraway Therapeutics for USD 610 Million to Boost Neurodegenerative Disease Portfolio

CompanyDrug

Janssen Submits Indication Extension Application to FDA for Rybrevant in NSCLC Treatment

CompanyDeals

EC Healthcare Partners with Jiangxi Rimag Group to Expand Medical Imaging Services

CompanyDeals

Dizal Pharmaceutical and Wuxi Gaofa Investment to Establish Joint Venture for Auto-Immune Disease Treatments

CompanyDeals

BeiGene Ltd Strikes Exclusive Global License Deal with Ensem Therapeutics for CDK2 Inhibitor

CompanyDrug

Fosun Pharmaceutical’s FCN-437c filing Accepted for Review by China’s NMPA

CompanyDeals

XtalPi Inc. and Singapore’s EDDC Broaden Collaboration in AI-Driven Drug Discovery

Company

Merck KGaA Completes Second Phase of Biologics Testing Center Expansion in China